UBS Group’s iPath Pure Beta Lead ETN LEDD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
– Sell
-653
Closed -$26K – 8607
2018
Q1
$26K Hold
653
– – ﹤0.01% 6238
2017
Q4
$27K Buy
653
+6
+0.9% +$252 ﹤0.01% 6344
2017
Q3
$26K Sell
647
-593
-48% -$22.9K ﹤0.01% 6287
2017
Q2
$47K Hold
1,240
– – ﹤0.01% 5702
2017
Q1
$48K Buy
1,240
+218
+21% +$8.31K ﹤0.01% 5560
2016
Q4
$34K Sell
1,022
-502
-33% -$18.5K ﹤0.01% 6149
2016
Q3
$54K Sell
1,524
-2
-0.1% -$64 ﹤0.01% 5458
2016
Q2
$46K Hold
1,526
– – ﹤0.01% 5590
2016
Q1
$44K Buy
1,526
+191
+14% +$5.82K ﹤0.01% 5603
2015
Q4
$40K Sell
1,335
-200
-13% -$5.72K ﹤0.01% 6045
2015
Q3
$44K Buy
1,535
+9
+0.6% +$266 ﹤0.01% 5958
2015
Q2
$46K Buy
1,526
+95
+7% +$3.15K ﹤0.01% 6076
2015
Q1
$44K Hold
1,431
– – ﹤0.01% 6183
2014
Q4
$46K Buy
+1,431
New +$50.7K ﹤0.01% 6597

UBS Group's LEDD Position: Q2 2018 in Review

UBS Group sold out of iPath Pure Beta Lead ETN (LEDD) in Q2 2018, closing a stake of 653 shares — an estimated $26K sold.

UBS Group first reported a position in LEDD in Q4 2014 and held it in 14 quarters. The position peaked at $54K in Q3 2016. 0 funds tracked by Wall St. Rank hold LEDD as of Q2 2018.

  • UBS Group reported no remaining iPath Pure Beta Lead ETN position as of Q2 2018 after selling out during the quarter.
  • UBS Group sold 653 iPath Pure Beta Lead ETN shares in Q2 2018, an estimated $26K.
  • UBS Group first reported a position in iPath Pure Beta Lead ETN in Q4 2014 and held it in 14 quarters.
  • UBS Group's iPath Pure Beta Lead ETN position peaked at $54K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held iPath Pure Beta Lead ETN as of Q2 2018.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.